Home

  WHO | "3 by 5" country information

Angola "3 by 5" country profile on treatment scale up, June 2005 pdf, 275kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 176kb Country health indicators 2. Belize "3 by 5" country profile on treatment scale up, June 2005 pdf, 184kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 113kb Country health indicators 3. Botswana "3 by 5" country profile on treatment scale up, June 2005 pdf, 282kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 200kb Country health indicators 4.

Score: 781288.1 - https://www.who.int/3by5/countryprofiles/en/

  WHO | "3 by 5" country information

Kenya "3 by 5" country profile on treatment scale up, June 2005 pdf, 345kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 253kb Country health indicators 27. Lesotho "3 by 5" country profile on treatment scale up, June 2005 pdf, 297kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 149kb Country health indicators 28. Malawi "3 by 5" country profile on treatment scale up, June 2005 pdf, 401kb Epidemiological fact sheet on HIV/AIDS and STIs pdf, 235kb Country health indicators 29.

Score: 778677.83 - https://www.who.int/3by5/countryprofiles/en/index1.html

  Microsoft Word - Guidelines on Art.14 from Decisions_WPE_16_12_2010.doc

There is clear scientific evidence that tobacco dependence treatment is effective and that it is a cost-effective health-care intervention, and thus that it is a worthwhile investment for health-care systems. 10. (...) Parties should provide cessation support and treatment in all health-care settings and by all health-care providers. (...) Implementing tobacco cessation and tobacco dependence treatment measures in conjunction with such policies will have a synergistic effect and thus maximize the impact on public health. 55.

Score: 771751.86 - https://www.who.int/fctc/treat...delines_Article_14_English.pdf

  Microsoft Word - Guidelines on Art.14 from Decisions_WPE_16_12_2010.doc

There is clear scientific evidence that tobacco dependence treatment is effective and that it is a cost-effective health-care intervention, and thus that it is a worthwhile investment for health-care systems. 10. (...) Parties should provide cessation support and treatment in all health-care settings and by all health-care providers. (...) Implementing tobacco cessation and tobacco dependence treatment measures in conjunction with such policies will have a synergistic effect and thus maximize the impact on public health. 55.

Score: 771751.86 - https://www.who.int/fctc/Guidelines.pdf

  WHO | Unprecedented opportunity to Fight HIV/AIDS and Change the course of History

Yet among all possible HIV- related interventions, the report says it is treatment that can most effectively boost prevention efforts and in turn drive the strengthening of health systems and enable poor countries to protect people from a wide range of health threats. (...) The report says the delivery of AIDS treatment and prevention also offers the chance to build up health systems in the poorest countries, providing health benefits for all. (...) The guidelines are intended to be used at all levels of the health system, as well as in the community to monitor and promote adherence to treatment.

Score: 771508.1 - https://www.who.int/3by5/report/en/

  Q and A

Standardizing and simplify- ing processes in this way also makes it easier to train the thousands of health care workers needed to increase access to treatment The number of treatment regimens recommended by WHO has been cut from 35 to four. (...) Adherence support will form an important component of the curricula for health care providers and treatment supporters which WHO is developing. (...) Globally up to 100,000 health workers and community treatment supporters need to be trained for their contribution to achieving the “3 by 5” target.

Score: 770143.55 - https://www.who.int/3by5/about/en/answers.pdf

  Hepatitis treatment: Turning promise into reality

Beyond the tragic loss of life and emotional impact on families and communities, hepatitis also imposes a tremendous cost to the health system, economy and society. A person who needs treatment for hepatitis B now but can’t afford it will end up costing the health system much more in the future if they develop liver disease. Once liver cancer develops, health costs escalate dramatically. In other words, not providing treatment now results in substantial costs to the health system later on. (...) The challenge now is to make sure that hepatitis B treatment is fully included in health insurance schemes, so that people living with hepatitis can get the treatment and care that they urgently need without crippling out-of-pocket expenses.

Score: 769494.73 - https://www.who.int/china/news...t-turning-promise-into-reality

  WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treat

WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. Select language Select language English العربية 中文 Français Русский Español Home Health Topics All topics » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Resources » Fact sheets Facts in pictures Multimedia Publications Questions & answers Tools and toolkits Popular » Coronavirus disease (COVID-19) Ebola virus disease Air pollution Hepatitis Top 10 causes of death World Health Assembly » Countries All countries » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Regions » Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific WHO in countries » Statistics Cooperation strategies Yemen crisis » Sadeq Al Wesabi Hasan An internally displaced family in a camp in Hudaydah © Credits   Newsroom All news » News releases Statements Campaigns Commentaries Events Feature stories Speeches Spotlights Newsletters Photo library Media distribution list Headlines » Timeline: WHO's COVID-19 response »   Emergencies Focus on » COVID-19 pandemic Ebola virus disease outbreak DRC 2021 Syria crisis Crisis in Northern Ethiopia Afghanistan Crisis Latest » Disease Outbreak News Travel advice Situation reports Weekly Epidemiological Record WHO in emergencies » Surveillance Research Funding Partners Operations Independent Oversight and Advisory Committee Health Emergency Dashboard » WHO © Credits Data Data at WHO » Global Health Estimates Health SDGs Mortality Triple billion targets Data collections Dashboards » COVID-19 Dashboard Triple Billion Dashboard Health Equity monitor Mortality Highlights » GHO SCORE Insights and visualizations Data collection tools Reports World Health Statistics 2021 » WHO © Credits About WHO About WHO » People Teams Structure Partnerships Collaborating Centres Networks, committees and advisory groups Transformation Our Work » General Programme of Work WHO Academy Activities Initiatives Funding » Assessed contributions Flexible funding WHO Foundation Accountability » Audit Budget Financial statements Programme Budget Portal Results Report Governance » World Health Assembly Executive Board Election of Director-General Governing Bodies website Home / Publications detail / WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment 15 June 2020  |  Guideline Download (1.7 MB) Overview Background Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). (...) In this regard, the WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment fulfills the mandate of WHO to inform health care professionals in Member States on how to improve treatment and care for patients with DR-TB.

Score: 768880.66 - https://www.who.int/publicatio...-detail-redirect/9789240007048

  WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treat

WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. Select language Select language English العربية 中文 Français Русский Español Português Home Health Topics All topics » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Resources » Fact sheets Facts in pictures Multimedia Publications Questions & answers Tools and toolkits Popular » Coronavirus disease (COVID-19) Ebola virus disease Air pollution Hepatitis Top 10 causes of death World Health Assembly » Countries All countries » A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Regions » Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific WHO in countries » Statistics Cooperation strategies Yemen crisis » Sadeq Al Wesabi Hasan An internally displaced family in a camp in Hudaydah © Credits   Newsroom All news » News releases Statements Campaigns Commentaries Events Feature stories Speeches Spotlights Newsletters Photo library Media distribution list Headlines » Timeline: WHO's COVID-19 response »   Emergencies Focus on » COVID-19 pandemic Ebola virus disease outbreak DRC 2021 Syria crisis Crisis in Northern Ethiopia Afghanistan Crisis Latest » Disease Outbreak News Travel advice Situation reports Weekly Epidemiological Record WHO in emergencies » Surveillance Research Funding Partners Operations Independent Oversight and Advisory Committee Health Emergency Dashboard » WHO © Credits Data Data at WHO » Global Health Estimates Health SDGs Mortality Triple billion targets Data collections Dashboards » COVID-19 Dashboard Triple Billion Dashboard Health Equity monitor Mortality Highlights » GHO SCORE Insights and visualizations Data collection tools Reports World Health Statistics 2021 » WHO © Credits About WHO About WHO » People Teams Structure Partnerships Collaborating Centres Networks, committees and advisory groups Transformation Our Work » General Programme of Work WHO Academy Activities Initiatives Funding » Assessed contributions Flexible funding WHO Foundation Accountability » Audit Budget Financial statements Programme Budget Portal Results Report Governance » World Health Assembly Executive Board Election of Director-General Governing Bodies website Home / Publications / i / item / WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment - Select language - العربية 中文 français русский español português WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment 15 June 2020  |  Guideline Download (1.7 MB) Overview Background Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). (...) In this regard, the WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment fulfills the mandate of WHO to inform health care professionals in Member States on how to improve treatment and care for patients with DR-TB.

Score: 766754.2 - https://www.who.int/publications/i/item/9789240007048

  World Health Organization and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005

World Health Organization and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005 Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) The simpler tests, combined with clinical evaluations by adequately trained health workers, can be effective in monitoring the progress of AIDS, the effectiveness of treatment and its side effects. (...) Thousands of community workers to be trained One of the most innovative aspects of the 3 by 5 strategy is a method for urgently training tens of thousands of community health workers to support the delivery and monitoring of HIV/AIDS treatment.

Score: 766422.75 - https://www.who.int/news/item/...-patients-on-treatment-by-2005